Judd CaulfieldAssociate General Counsel, US Rx Business Unit at GaldermaSpeaker
Agenda Sessions
Navigating Drug Portfolio Change Impacts on Government Program Participation
, 11:35amView SessionPreparing for the Inevitable: Navigating Proposed PBM Reforms and FTC Transparency Mandates
, 3:35pmView Session
